Dynamics and control of Schistosoma haematobium transmission in Kenya: An overview of the Msambweni project

American Journal of Tropical Medicine and Hygiene

Volumn 55, Issue 5 SUPPL., 1996, Pages 127-134

  Muchiri, Eric M ^a   Ouma, John H ^a   King, Charles H ^b  

^a MINISTRY OF HEALTH   (Kenya)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONFERENCE PAPER; ENDEMIC DISEASE; HIGH RISK POPULATION; HUMAN; INFECTION CONTROL; KENYA; MASS SCREENING; MONITORING; PARASITE TRANSMISSION; PREVALENCE; SCHISTOSOMIASIS; WATER SUPPLY;

GASTROPODA; SCHISTOSOMA HAEMATOBIUM;

EID: 0029847493     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.1996.55.127     Document Type: Conference Paper

References (20)

1. King CH, Lombardi G, Lombardi C, Greenblatt R, Hodder S, Kinyanjui H, Ouma J, Odihambo O, Bryan PJ, Muruka J, Magak P, Weinert D, Mackay W, Ransohoff D, Houser H, Koech D, Siongok TK, Mahmoud AAF, 1988. Chemotherapy-based control of schistosomiasis haematobia. I. Metrifonate versus praziquantel in control of intensity and prevalence of infection. Am J Trop Med Hyg 39: 295-305.
2. King CH, Lombardi G, Lombardi C, Greenblatt R, Hodder S, Kinyanjui H, Ouma J, Odihambo O, Bryan PJ, Muruka J, Magak P, Weinert D, Ransohoff D, Houser H, Koech D, Siongok TK, Mahmoud AAF, 1990. Chemotherapy-based control of schistosomiasis haematobia. II. Metrifonate versus praziquantel in control of infection-associated morbidity. Am J Trop Med Hyg 42: 587-595.
3. King CH, Muchiri EM, Ouma JH, Koech D, 1991. Chemotherapy-based control of schistosomiasis haematobia. IV. Impact of repeated annual chemotherapy on prevalence and intensity of Schistosoma haematobium infection in an endemic area of Kenya. Am J Trop Med Hyg 45: 498-508.
4. El Kholy H, Arap Siongok TK, Koech D, Sturrock RF, Houser H, King CH, Mahmoud AAF, 1989. Effects of borehole wells on water utilization in Schistosoma haematobium-endemic communities in Coast Province, Kenya. Am J Trop Med Hyg 41: 212-219.
5. Sturrock RF, Kinyanjui H, Thiongo FW, Tosha S, Ouma JH, King CH, Koech D, Siongok TK, Mahmoud AAF, 1990. Chemotherapy-based control of Schistosoma haematobium. 3. Snail studies monitoring the effect of chemotherapy on transmission in Msambweni area, Kenya. Trans R Soc Trop Med Hyg 84: 257-261.
6. Dalton PR, Pole D, 1978. Water contact patterns in relation to Schistosoma haematobium infection. Bull World Health Organ 56: 417-422.
7. Barbour AD, 1985. The importance of age and water contact pattern in relation to Schistosoma haematobium infection. Trans R Soc Trop Med Hyg 79: 151-153.
8. Wilkins HA, Goll PH, Marshall TF, Moore PJ, 1984. Dynamics of Schistosoma haematobium infection in a Gambian community. I. The pattern of human infection in the study area. Trans R Soc Trop Med Hyg 78: 216-221.
9. Warren KS, Mahmoud AAF, 1976. Targeted mass treatment: a new approach to the control of schistosomiasis. Trans Assoc Am Physicians 89: 195-204.
10. Mahmoud AAF, Siongok TK, Ouma JH, Houser HB, Warren KS, 1983. Effect of targeted mass treatment on intensity of infection and morbidity in schistosomiasis mansoni: three year follow-up of a community in Machakos, Kenya. Lancet i: 849-851.
11. Warren KS, Mahmoud AAF, Muruka JF, Whittaker LR, Ouma JH, Siongok TK, 1979. Schistosomiasis haematobia in Coast province, Kenya. Relationship between egg output and morbidity. Am J Trop Med Hyg 28: 864-870.
12. King CH, Keating CE, Muruka JF, Ouma JH, Houser H, Arap Siongok TK, Mahmoud AAF, 1988. Urinary tract morbidity in schistosomiasis haematobia: associations with age and intensity of infection in an endemic area of Coast Province, Kenya. Am J Trop Med Hyg 39: 361-368.
13. Anderson RM, May RM, 1982. Population dynamics of human helminth infections: control by chemotherapy. Nature 297: 557-563.
14. Warren KS, Arap Siongok TK, Houser HB, Ouma JH, Peters PA, 1978. Quantification of infection with Schistosoma haematobium in relation to epidemiology and selective population chemotherapy. I. Minimal number of daily egg counts in urine necessary to establish intensity of infection. J Infect Dis 138: 849-855.
15. Savioli L, Hatz C, Dixon H, Kisumku UM, Mott KE, 1990. Control of morbidity due to Schistosoma haematobium on Pemba Island: egg excretion and hematuria as indicators of infection. Am J Trop Med Hyg 43: 289-295.
16. King CH, Wiper DW, De Stigter KV, Peters PAS, Koech D, Ouma JH, Arap Siongok TK, Mahmoud AAF, 1989. Dose-finding for praziquantel therapy of Schistosoma haematobium in Coast Province, Kenya. Am J Trop Med Hyg 40: 507-513.
17. Siongok TK, Ouma JH, Houser HB, Warren KS, 1978. Quantification of infection with Schistosoma haematobium in relation to epidemiology and selective population chemotherapy. II. Mass treatment with a single oral dose of metrifonate. J Infect Dis 138: 856-858.
18. Warren KS, 1973. Regulation of prevalence and intensity of schistosomiasis in man: immunology or ecology?. J Infect Dis 127: 595-609.
19. Wilkins HA, Blumenthal UJ, Hayes RJ, Tulloch S, 1987. Resistance to reinfection of urinary schistosomiasis. Trans R Soc Trop Med Hyg 81: 29-35.
20. Hagan P, Blumenthal UJ, Dunn D, Simpson AJG, Wilkins HA, 1991. Human IgE, IgG4 and resistance to reinfection with Schistosoma haematobium. Nature 349: 243-245.